ControlPoint Inc. Chosen for Newchip’s Seed-Stage Global Accelerator Program
Animal diagnostics start-up among top applicants selected for Newchip’s exclusive accelerator
Campbell, Calif. -- ControlPoint Inc., an animal diagnostics company focused on developing tests that could be used by anyone, anywhere, has been accepted into Newchip’s renowned global accelerator program. Designed to provide all the skills and tools seed-stage founders need to rapidly fund, build and scale their companies, past accelerator cohorts averaged more than 17.5 times the average funding amount. The equity-free, fully digital accelerator has helped more than 1,500 founders from more than 50 countries and 250 cities raise over $450 million in funding with an estimated portfolio of more than $9 billion.
“Newchip evaluates a vast and diverse number of seed-stage companies from around the globe, selecting only a small percentage to be part of our Seed Accelerator program,” says Armando Vera Carvajal, vice president of product at Newchip. “This careful vetting process of both the business model and founder makes us an ideal partner for venture capital investors and other key stakeholders in early-stage startup financings who are looking for promising startups that are beginning to generate traction and revenue. Animal diagnostics companies such as ControlPoint Inc. can scale quickly with proper funding and guidance. We are excited for ControlPoint and believe they will be well positioned to take advantage of our fast-expanding global ecosystem at Newchip.”
Launched in 2020, ControlPoint is on a mission to improve the health and well-being of animals around the globe. Since launching, the company has filed their provisional patent, demonstrated proof of concept and initiated product development.
“Being part of the Newchip Accelerator will enable us to move ahead more quickly and efficiently in bringing point-of-service testing to animal health providers, said ControlPoint CEO Paula Walker. “When pet health is at risk, fast, accurate testing and diagnoses are critical. ControlPoint will bring innovative new tools to veterinarians and others who care for pets.”
About ControlPoint Inc.
ControlPoint Inc. is an animal diagnostics company focused on developing tests that could be used by anyone, anywhere, providing results within minutes. We are currently working on a point-of-care test that identifies multiple pathogens, providing veterinarians with an easy-to-use and fast test. To learn more, visit www.controlpointdx.com.
About Newchip
Newchip is an online, global startup accelerator led by a world-class team of entrepreneurs and investors. It was designed to provide founders with the tools needed to rapidly fund, build, and scale. Since its inception in 2019, the equity-free, remote accelerator has enabled over 1,500 startups from 50+ countries to raise over $450 million in funding with an estimated $9B portfolio. It has three distinct six-month accelerator programs based on company stage: Pre-Seed, Seed, and Series A. Its vast network of global investors, strategic partners, and mentors guide companies from team building and prototype development to securing high-profile VC investment, corporate partnerships, and everything in-between. To learn more, visit https://launch.newchip.com/.
For press inquires contact info@controlpointdx.com or Sharon Polk, 913-221-5834; spolk@dmgcommunication.com